Comparison of the efficacy of Rosa damascena extract and mefenamic acid on the severity of the primary dysmenorrhea pai
Phase 3
- Conditions
- primary dysmenorrhea.Primary dysmenorrhea
- Registration Number
- IRCT201207267618N2
- Lead Sponsor
- Research deputy of Tabriz University of Medical Sience
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 92
Inclusion Criteria
women with abdominal pain compatible with dysmenorrhea; being single; signing the informed consent sheet.
Exclusion criteria: pain severity more than 8 or less than 5 according to visual analogue scale system; history of genitourinary disease or abdomino-pelvic surgery; stressful event(loss); lack of compliancy; history of hypersensitivity to mefenamic acid; using drugs that interact with mefenamic acid.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of dysmenorrhea pain. Timepoint: before the first intervention, after the first intervention, before the second intervention, after the second intervention. Method of measurement: visual analogue scale.
- Secondary Outcome Measures
Name Time Method